5g of This Focus Drug Beats Any Nootropic In 2026

Wellness / Self-care & Productivity Strategies Highlighted

• Use “neurpetic” (mind-shaping) supplements for cognitive performance—without stimulant/sedative effects

  • Emphasis on paracetam (and related racetams) being:
    • Not a classic stimulant
    • Not sedating
    • Not strongly tied to large dopamine/heart-rate jumps
    • Potentially neuroprotective and supportive of learning/adaptation

• Prioritize “fundamentals” before nootropics

  • Start with basics like:
    • Avoiding toxins
    • Fixing gut health
    • Eating appropriate foods
  • Then consider racetams as an upgrade layer.

• Dosing approach: “start low, go slower”

  • Paracetam
    • Typical range: ~1.5 g to 5 g/day, split into divided doses
    • Strategy: start low and increase gradually
  • If you get side effects (e.g., headaches), adjust via the choline strategy (below) rather than abruptly stopping.

• Choline support to match acetylcholine demand

  • Racetams may increase reliance on the brain’s acetylcholine system.
  • Suggested choline sources and targets:
    • CDP-choline (citicoline): ~250–500 mg
    • Alpha-GPC: ~300–600 mg
  • Practical “tuning” rule:
    • If you get muscle tension/jaw tension, you may already have enough acetylcholine—reduce choline or avoid alpha-GPC daily.

• Choose racetams based on the cognitive effect you want (function-specific)

  • Aniracetam (“AMP”/glutamate/AMP-focused; short-acting)
    • Used for: memory, anti-stress, mood/anxiety support (including animal evidence)
    • Typical dosing referenced: ~750–1,500 mg/day
  • Oxiracetam
    • Used for: analytical/structured work (coding, concentration, mental stamina)
    • Typical dosing referenced: ~800 mg once or twice daily
  • Pramiracetam (“memory specialist”)
    • Used for: memory/recall after brain injury or oxygen deprivation
    • Typical dosing referenced: ~400–1,200 mg/day
  • Phenylparacetam
    • Used for: alertness, motivated focus, endurance
    • Typical dosing referenced: ~100–200 mg once or twice daily
    • Noted behavior: can feel more “stim-like,” and tolerance may develop; described as not ideal as a constant daily driver.

• Stacking guidance (keep it simple; reduce variables)

  • Racetam + choline: commonly recommended.
  • Racetam + caffeine: “works great,” but phenylparacetam + extra caffeine can cause overstimulation.
  • Omega-3s:
    • Presenter suggests taking EPA/DHA on their own without relying on racetams for their effect (may help membrane fluidity theoretically).
  • Avoid stacking racetams on racetams too much
    • Preferred: use one as the base; layering increases uncertainty (no trials for many combinations).
    • Suggested layering only when you “need extra output” (e.g., phenylparacetam).
  • Modafinil: racetams described as stacking well (mentioned as a known combo in other content).

• Track objective signals (self-experimentation)

  • Example metric:
    • Whether you still “grasp for words”
    • Improvement is framed as: recall becomes effortless and frequent word-lapses drop.
  • Recommendation timeline:
    • Try paracetam alone for ~3 weeks, expect gradual effects.

• Safety & Personalization Cautions

  • Side effects reported/possible with paracetam: headaches, insomnia, agitation/irritability, anxiety, GI symptoms, brain fog (presenter suggests complex underlying factors may be involved).
  • Extra caution if:
    • Kidney dysfunction
    • Seizure disorder
    • Psychiatric medication use / heavy drug stacks
    • Pregnancy/breastfeeding
    • Competitive athletes (and anti-doping rules)
  • General principle:
    • Lack of safety data ≠ automatically safe; weigh theoretical risk yourself.

• Brain Protection Rationale (Use-case Framing)

  • Presenter repeatedly frames racetams as neuroprotective, with use scenarios including:
    • Stroke/dementia contexts (by neurologists/rehab physicians in the presenter’s framing)
    • Post-injury/aphasia considerations
    • For sedation/anesthesia situations: mentions telling anesthesiologists and/or using racetams beforehand (with the caveat anesthesiologists may advise against it).

• Productivity / Performance for Specific Roles

  • Phenylparacetam is positioned for:
    • Poker, day trading, students, surgeons/anesthesiologists, harsh environments, travel/jet lag
    • Endurance and situations involving hypoxia/head trauma risk

---

Presenters / Sources Mentioned

People / Organizations

• Dave Asprey (“The Human Upgrade” host/presenter)
• Steve Fols (mentor/friend; “Smart Drug News”)
• Cornell Georga (UCB Belgium; coined term “neutropic” in the 1960s)
• Sandos Pharmaceuticals

Research / Publication Mentions

• UCB / Belgium lab work (1960s)
• 2002 meta-analysis of paracetam trials (19 double-blind placebo-controlled trials)
• 2010 Frontiers in Neuroscience (paracetam mitochondrial function; referenced as “Lunar Atal 2010”)
• 2024 meta-analysis (memory-focused; 18 studies referenced)
• 2016 systematic review (Zang Atal; aphasia after stroke; journal named CNS Drugs)
• Stockberger Edal (follow-up linking mitochondrial effects to neuroplasticity/mitochondrial movement; study referenced ~6 years later)

Regulatory / Standards Sources Mentioned

• FDA
• Daily Med
• Orange Book
• Purple Book
• PDR
• World Anti-Doping Authority (WADA)